IBDEI11V ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18514,0)
 ;;=198.1^^102^1190^3
 ;;^UTILITY(U,$J,358.3,18514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18514,1,4,0)
 ;;=4^CA METS TO URIN NEC
 ;;^UTILITY(U,$J,358.3,18514,1,5,0)
 ;;=5^198.1
 ;;^UTILITY(U,$J,358.3,18514,2)
 ;;=^267332
 ;;^UTILITY(U,$J,358.3,18515,0)
 ;;=189.4^^102^1190^11
 ;;^UTILITY(U,$J,358.3,18515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18515,1,4,0)
 ;;=4^MAL NEO PARAURETHRAL
 ;;^UTILITY(U,$J,358.3,18515,1,5,0)
 ;;=5^189.4
 ;;^UTILITY(U,$J,358.3,18515,2)
 ;;=^267267
 ;;^UTILITY(U,$J,358.3,18516,0)
 ;;=189.1^^102^1190^12
 ;;^UTILITY(U,$J,358.3,18516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18516,1,4,0)
 ;;=4^MAL NEO RENAL PELVIS
 ;;^UTILITY(U,$J,358.3,18516,1,5,0)
 ;;=5^189.1
 ;;^UTILITY(U,$J,358.3,18516,2)
 ;;=^267264
 ;;^UTILITY(U,$J,358.3,18517,0)
 ;;=189.2^^102^1190^17
 ;;^UTILITY(U,$J,358.3,18517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18517,1,4,0)
 ;;=4^MAL NEO URETER
 ;;^UTILITY(U,$J,358.3,18517,1,5,0)
 ;;=5^189.2
 ;;^UTILITY(U,$J,358.3,18517,2)
 ;;=^267265
 ;;^UTILITY(U,$J,358.3,18518,0)
 ;;=189.3^^102^1190^18
 ;;^UTILITY(U,$J,358.3,18518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18518,1,4,0)
 ;;=4^MAL NEO URETHRA
 ;;^UTILITY(U,$J,358.3,18518,1,5,0)
 ;;=5^189.3
 ;;^UTILITY(U,$J,358.3,18518,2)
 ;;=^267266
 ;;^UTILITY(U,$J,358.3,18519,0)
 ;;=174.6^^102^1190^5
 ;;^UTILITY(U,$J,358.3,18519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18519,1,4,0)
 ;;=4^MAL NEO BREAST-AXILLARY
 ;;^UTILITY(U,$J,358.3,18519,1,5,0)
 ;;=5^174.6
 ;;^UTILITY(U,$J,358.3,18519,2)
 ;;=^267200
 ;;^UTILITY(U,$J,358.3,18520,0)
 ;;=174.1^^102^1190^6
 ;;^UTILITY(U,$J,358.3,18520,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18520,1,4,0)
 ;;=4^MAL NEO BREAST-CENTRAL
 ;;^UTILITY(U,$J,358.3,18520,1,5,0)
 ;;=5^174.1
 ;;^UTILITY(U,$J,358.3,18520,2)
 ;;=^267195
 ;;^UTILITY(U,$J,358.3,18521,0)
 ;;=174.0^^102^1190^10
 ;;^UTILITY(U,$J,358.3,18521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18521,1,4,0)
 ;;=4^MAL NEO NIPPLE
 ;;^UTILITY(U,$J,358.3,18521,1,5,0)
 ;;=5^174.0
 ;;^UTILITY(U,$J,358.3,18521,2)
 ;;=^73528
 ;;^UTILITY(U,$J,358.3,18522,0)
 ;;=171.2^^102^1190^13
 ;;^UTILITY(U,$J,358.3,18522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18522,1,4,0)
 ;;=4^MAL NEO SOFT TIS ARM
 ;;^UTILITY(U,$J,358.3,18522,1,5,0)
 ;;=5^171.2
 ;;^UTILITY(U,$J,358.3,18522,2)
 ;;=^267167
 ;;^UTILITY(U,$J,358.3,18523,0)
 ;;=171.3^^102^1190^14
 ;;^UTILITY(U,$J,358.3,18523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18523,1,4,0)
 ;;=4^MAL NEO SOFT TIS LEG
 ;;^UTILITY(U,$J,358.3,18523,1,5,0)
 ;;=5^171.3
 ;;^UTILITY(U,$J,358.3,18523,2)
 ;;=^267168
 ;;^UTILITY(U,$J,358.3,18524,0)
 ;;=171.6^^102^1190^15
 ;;^UTILITY(U,$J,358.3,18524,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18524,1,4,0)
 ;;=4^MAL NEO SOFT TIS PELVIS
 ;;^UTILITY(U,$J,358.3,18524,1,5,0)
 ;;=5^171.6
 ;;^UTILITY(U,$J,358.3,18524,2)
 ;;=^267171
 ;;^UTILITY(U,$J,358.3,18525,0)
 ;;=171.4^^102^1190^16
 ;;^UTILITY(U,$J,358.3,18525,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18525,1,4,0)
 ;;=4^MAL NEO SOFT TIS THORAX
 ;;^UTILITY(U,$J,358.3,18525,1,5,0)
 ;;=5^171.4
 ;;^UTILITY(U,$J,358.3,18525,2)
 ;;=^267169
 ;;^UTILITY(U,$J,358.3,18526,0)
 ;;=200.68^^102^1191^1
 ;;^UTILITY(U,$J,358.3,18526,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18526,1,4,0)
 ;;=4^ANAPLASTIC LG CELL LYMPHOMA
 ;;^UTILITY(U,$J,358.3,18526,1,5,0)
 ;;=5^200.68
 ;;^UTILITY(U,$J,358.3,18526,2)
 ;;=^335220
 ;;^UTILITY(U,$J,358.3,18527,0)
 ;;=200.28^^102^1191^2
 ;;^UTILITY(U,$J,358.3,18527,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,18527,1,4,0)
 ;;=4^BURKITT'S TUMOR MULT
 ;;
 ;;$END ROU IBDEI11V
